New Global Collaboration On Inspecting Sterile Drug Manufacturers
Initiative Builds On Success Of Similar Program For API Inspections
Executive Summary
Drug regulatory authorities from around the world are participating in a new initiative that allows them to collaborate on the inspection of manufacturers of sterile medicines located in third countries.